Registration NOW open for the Best of ASRM and ESHRE 2025 !

Update of the Evidence based guideline on Premature Ovarian Insufficiency – now published

Premature Ovarian Insufficiency (POI) presents a significant challenge to women's health, with far-reaching implications, both physically and emotionally. To improve the care of women with POI, an international expert group, including representation from ESHRE, ASRM, CRE-WHiRL and IMS collaborated to address 40 key questions through 145 recommendations.
For professionals involved in the care for women with POI, this is a must-read document.


PGT troubleshooting from intake to follow-up seminar - join the 2024 edition

This comprehensive seminar will help guide professionals through the different steps of the Preimplantation Genetic Testing (PGT) process, from the initial intake of patients to successful post-procedure follow-up.


Women with premature ovarian insufficiency are at greater risk of severe autoimmune diseases

Human Reproduction Press Release
Severe autoimmune conditions such Type I diabetes, Addison’s disease, lupus and inflammatory bowel disease, are between two to three times more common in women who have been diagnosed with premature ovarian insufficiency (POI) compared to the general population.


ESGO-ESHRE-ESGE guidelines for fertility-sparing in gynecologic cancer now published

The European Society of Gynaecological Oncology, the European Society of Human Reproduction and Embryology, and the European Society for Gynaecological Endoscopy jointly developed clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing strategies and follow-up of patients with cervical cancers, ovarian cancers, and borderline ovarian tumours.